| 臺大學術典藏 |
2020-05-25T07:35:05Z |
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
|
Weiss G.J.;Zhang Z.-Y;Chan J;Hughes L;Bobilev D;Su W.-C;Dziadziuszko R;Mita M;de Castro Carpe?o J;Sachdev J;Lu S;Arkenau H.-T;Chia-Chi Lin; Chia-Chi Lin; Arkenau H.-T; Lu S; Sachdev J; de Castro Carpe?o J; Mita M; Dziadziuszko R; Su W.-C; Bobilev D; Hughes L; Chan J; Zhang Z.-Y; Weiss G.J. |
| 臺大學術典藏 |
2020-05-25T07:35:01Z |
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
|
Chia-Chi Lin; Akimov M; Ghebremariam S; Hong D; Poon R.T.P; Azaro A; Lim W.T; Bauer T.M; Nam D.-H; Schuler M; Su W.-C; Bang Y.-J; Zhao S; Giovannini M; Ma B. |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:11Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.-H.; Kang Y.K.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Chiun Hsu; Cheng A.-L.; Yang T.-S.; Shun C.-T.; Shao Y.-Y. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:16:09Z |
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study
|
Hsu C.; Cheng A.-L.; Jin K.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; Shun C.-T.; YU-YUN SHAO; Su W.-C.; Sandoval-Tan J.; Chiou T.-J. |
| 臺大學術典藏 |
2020-03-24T07:00:40Z |
Factors associated with myocardial infarction after emergency endoscopy for upper gastrointestinal bleeding in high-risk patients: a prospective observational study
|
Wang H.-P.;Lin J.-T.;CHIEN-HUA HUANG;Su W.-C.;Tai C.-M.;Chiang T.-H.;Cheng T.-Y.;Huang S.-P.;Lee C.-T.; Lee C.-T.; Huang S.-P.; Cheng T.-Y.; Chiang T.-H.; Tai C.-M.; Su W.-C.; CHIEN-HUA HUANG; Lin J.-T.; Wang H.-P. |
| 臺大學術典藏 |
2020-03-05T08:16:37Z |
Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1-deficient mice
|
Chen Y.-C.;Su Y.-C.;Shieh G.-S.;Su B.-H.;Su W.-C.;Pei-Hsin Huang;Jiang S.-T.;Shiau A.-L.;Wu C.-L.; Chen Y.-C.; Su Y.-C.; Shieh G.-S.; Su B.-H.; Su W.-C.; PEI-HSIN HUANG; Jiang S.-T.; Shiau A.-L.; Wu C.-L. |
| 臺大學術典藏 |
2020-03-02T07:41:00Z |
Polythiophene derivative comprising carbazoles as pendant groups for polymer solar cell applications
|
Wang, H.-J.; Chan, L.-H.; Chen, C.-P.; Lee, R.-H.; Su, W.-C.; Jeng, R.-J.; RU-JONG JENG |
| 臺大學術典藏 |
2020-03-02T07:40:59Z |
Iterative synthesis of monodisperse pendants for making comb-like polyurethanes
|
RU-JONG JENG; Chen, S.-C.; Tung, S.-H.; Lee, R.-H.; Su, W.-C.; Jeng, R.-J.; Wu, C.-H.; Chen, Y.-C.; Dai, S.A. |
| 臺大學術典藏 |
2020-03-02T07:40:52Z |
A Facile Synthetic Route to Ether Diols Derived from 1,1-Cyclopentylenylbisphenol for Robust Cardo-Type Polyurethanes
|
Wu, C.-H.; Lin, Y.-R.; Yeh, S.-C.; Huang, Y.-C.; Sun, K.-H.; Shih, Y.-F.; Su, W.-C.; Dai, C.-A.; Dai, S.A.; Jeng, R.-J.; RU-JONG JENG |
| 臺大學術典藏 |
2020-02-17T07:43:32Z |
Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression
|
Chang T.-S; Wu Y.-C; Chi C.-C; Su W.-C; Chang P.-J; Lee K.-F; Tung T.-H; Wang J; Liu J.-J; Tung S.-Y; Kuo L.-M; HONG-NERNG HO; Ling T.-Y; Huang Y.-H. |
| 臺大學術典藏 |
2020-02-15T03:52:38Z |
Employee ownership motivation and individual risk-taking behaviour: A cross-level analysis of Taiwan's privatized enterprises
|
Wu, H.-L.;Su, W.-C.;Lee, C.-Y.; Wu, H.-L.; Su, W.-C.; Lee, C.-Y.; HSUEH-LIANG WU |
| 臺大學術典藏 |
2020-02-14T07:49:07Z |
Employee ownership motivation and individual risk-taking behaviour: A cross-level analysis of Taiwan's privatized enterprises
|
Wu, H.-L.; Su, W.-C.; Lee, C.-Y.; HSUEH-LIANG WU |
| 臺大學術典藏 |
2020-02-14T02:49:50Z |
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
|
Kwak E.L.; Shapiro G.I.; Cohen S.M.; Becerra C.R.; Lenz H.-J.; WEN-FANG CHENG; Su W.-C.; Robohn M.; Le Maulf F.; Lobmeyer M.T.; Chand V.K.; Iafrate A.J. |
| 臺大學術典藏 |
2020-02-11T07:58:53Z |
Tension pneumothorax after an ERCP in a patient with hepatic hydrothorax and sealed-off perforated duodenal ulcer
|
Han M.-L.; YAO-MING WU; Liu K.-L.; Su W.-C.; Wang H.-P. |
| 臺大學術典藏 |
2020-02-10T09:00:52Z |
Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis
|
Hsu C.-H.;Lin S.-S.;Liu F.-L.;Su W.-C.;Yeh S.-D.; Hsu C.-H.; Lin S.-S.; Liu F.-L.; Su W.-C.; Yeh S.-D.; SHIH-SHUN LIN |
| 臺大學術典藏 |
2020-02-06T05:22:03Z |
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
|
Iafrate A.J.;Chand V.K.;Lobmeyer M.T.;Le Maulf F.;Robohn M.;Su W.-C.;WEN-FANG CHENG;Lenz H.-J.;Becerra C.R.;Cohen S.M.;Shapiro G.I.;Kwak E.L.; Kwak E.L.; Shapiro G.I.; Cohen S.M.; Becerra C.R.; Lenz H.-J.; WEN-FANG CHENG; Su W.-C.; Robohn M.; Le Maulf F.; Lobmeyer M.T.; Chand V.K.; Iafrate A.J.; Kwak E.L.; Shapiro G.I.; Cohen S.M.; Becerra C.R.; Lenz H.-J.; WEN-FANG CHENG; Su W.-C.; Robohn M.; Le Maulf F.; Lobmeyer M.T.; Chand V.K.; Iafrate A.J. |
| 臺大學術典藏 |
2020-01-06T03:03:53Z |
A Facile Synthetic Route to Ether Diols Derived from 1,1-Cyclopentylenylbisphenol for Robust Cardo-Type Polyurethanes
|
CHI-AN DAI; Jeng, R.-J.; Wu, C.-H.; Lin, Y.-R.; Yeh, S.-C.; Huang, Y.-C.; Sun, K.-H.; Shih, Y.-F.; Su, W.-C.; Dai, C.-A.; Dai, S.A. |
| 國立臺灣科技大學 |
2020 |
Nitrogen-Doped microporous carbons derived from azobenzene and nitrile-functionalized polybenzoxazines for CO2 uptake
|
Mohamed, Mohamed M.G.;Tsai, M.-Y.;Su, W.-C.;EL-Mahdy, A.F.M.;Wang, C.-F.;Huang, C.-F.;Dai, L.;Chen, T.;Kuo, S.-W. |
| 臺大學術典藏 |
2020 |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Shaw A.T.; Passos V.Q.; Chen Z.; Viraswami-Appanna K.; Spigel D.R.; Scagliotti G.V.; Mok T.; Su W.-C.; Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Nishio M.;Felip E.;Orlov S.;Park K.;Chong-Jen Yu;Tsai C.-M.;Cobo M.;Mckeage M.;Su W.-C.;Mok T.;Scagliotti G.V.;Spigel D.R.;Viraswami-Appanna K.;Chen Z.;Passos V.Q.;Shaw A.T. |
| 國立成功大學 |
2020 |
Influence of Hot Carriers and Illumination Stress on a-InGaZnO TFTs with Asymmetrical Geometry
|
Hung, Y.-H.;Chang, T.-C.;Chen, P.-H.;Liao, P.-Y.;Su, W.-C.;Chen, H.-C.;Tu, Y.-F.;Zheng, Y.-Z.;Lu, I.-N.;Lin, Y.-S.;Ciou, F.-M.;Tsai, Tsai T.-M. |
| 國立成功大學 |
2020 |
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
|
Chen, Y.-M.;Chih-Hsin, Yang J.;Su, W.-C.;Chong, I.-W.;Hsia, T.-C.;Lin, M.-C.;Chang, G.-C.;Chiu, Chiu C.-H.;Ho, C.-C.;Wu, S.-Y.;Hung, J.-Y.;Wang, C.-C.;Yang, T.-Y.;Yu, C.-J. |
| 國立成功大學 |
2020 |
Comparative effectiveness and costeffectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan
|
Yang, S.-C.;Lai, W.-W.;Hsu, J.C.;Su, W.-C.;Wang, J.-D. |
